PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin - authors' reply

Aliment Pharmacol Ther. 2014 Dec;40(11-12):1367-8. doi: 10.1111/apt.12995.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Ulcer Agents / therapeutic use*
  • Aspirin / adverse effects*
  • Duodenal Ulcer / drug therapy*
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Male
  • Rabeprazole / therapeutic use*
  • Stomach Ulcer / drug therapy*

Substances

  • Anti-Ulcer Agents
  • Fibrinolytic Agents
  • Rabeprazole
  • Aspirin